BREAST BIOPSY

Course overview

WITH IMPROVED SCREENING AND DIAGNOSTIC TECHNIQUES, THE INCIDENCE AND PREVALENCE OF BREAST CANCER ARE RISING WORLDWIDE. IN 2018 ALONE, THERE WERE 2.2 MILLION CASES OF BREAST CANCER DIAGNOSED WORLDWIDE, AND MOST WERE DISCOVERED BY IMAGING. HOWEVER, THERE ARE LIMITATIONS TO BREAST IMAGING EVALUATION. THE MAJORITY OF SUSPICIOUS BREAST LESIONS REQUIRE FURTHER DIAGNOSTIC WORKUP WITH A BIOPSY AND PATHOLOGICAL DIAGNOSIS TO DETERMINE MANAGEMENT. THIS ACTIVITY DESCRIBES HOW TO PERFORM AN ULTRASOUND, MAMMOGRAPHIC STEREOTACTIC, AND MAGNETIC RESONANCE (MR) GUIDED BREAST BIOPSY AND EXPLAINS THE ROLE OF THE MACHINES, PROCEDURAL TEAM, AND TECHNIQUES USED IN EVALUATING AND MANAGING SUSPICIOUS BREAST MASSES IN PATIENTS WHO UNDERGO IMAGING-GUIDED BIOPSIES.